GSK

News

GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio

A court ruling in the US has delivered a setback for GSK and its Tesaro subsidiary in their dispute with AnaptysBio over cancer drug Jemperli.

News

Multiple myeloma drug Blenrep backed for wider NHS use

The revitalisation of GSK's Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple myeloma drug more widely.

News

Data backs GSK's ovarian cancer blockbuster hopes

GSK's B7-H4-targeting ADC Mo-Rez chalks up impressive results in ovarian and endometrial cancer, prompting a major phase 3 trials programme.

News

Meningitis outbreak in UK prompts call to widen vaccination

A UK patient group is calling for changes to the decade-old meningitis vaccination programme, after an outbreak in Kent killed two young people.

News

GSK's RSV shot cleared in US for all adults

GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.

News

Multicoloured letters with AUTISM spelled in the middle

FDA approves leucovorin – but not for autism

The FDA stops short of approving leucovorin for autism, but will its clearance for ultra-rare condition CFD-FOLR1 lead to more off-label prescribing?

GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio

Multiple myeloma drug Blenrep backed for wider NHS use

Data backs GSK's ovarian cancer blockbuster hopes

Meningitis outbreak in UK prompts call to widen vaccination

GSK's RSV shot cleared in US for all adults

FDA approves leucovorin – but not for autism

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

GSK

Editor's Picks